Mayne Pharma Group Ltd has released a press release.
MYX completes sale of US retail generics business for US$90m
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Update on sale of US retail generics portfolio
- Mayne Pharma announces cancellation of capital return
- 2023 Half Year Investor Presentation
- 2022 Half Year Media Release
- Mayne Pharma announces sale of US retail generics business
Later from Mayne Pharma
- Mayne Pharma May 2023 market update presentation
- MYX provides investor update & announces on market buyback
- Preliminary Final Report
- 2023 Full Year Results Media Release
- 2023 Full Year Results Investor Presentation
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma